If you don't feel hungry as much as you used to, or you are not wanting to eat as much food as you would usually, this could ...

A 14-gene molecular assay could help predict which patients with early-stage non-small cell lung cancer will benefit from ...

AstraZeneca and Daiichi Sankyo’s drug extended survival by 30% compared to a widely used regimen, further establishing its ...

Key results from the interim analysis of the Phase 3 ENLIGHTED study of Padeliporfin VTP: As of November 5, 2024, the data ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive final results from the overall survival (OS) analysis of the Phase III INAVO120 study. These data showed ...

GREENWICH, CT, CT, UNITED STATES, May 30, 2025 /EINPresswire.com/ -- Breast Cancer Alliance (BCA), one of the nation’s leading and most impactful nonprofit breast cancer organizations, proudly ...

Officially completing its acquisition of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT), Sun Pharmaceutical Industries Ltd. has ...

The envisioned flow cytometry test will help to predict patient response to immunotherapies for five cancer indications.

A molecular test identified patients with high-risk early lung cancer who significantly benefitted from adjuvant chemotherapy ...

Today, cancer stage and tumor size tell which patients will receive adjuvant chemotherapy. But the rise of biomarker testing ...

Two studies reveal promising treatments for breast cancer, enhancing options for patients with triple-negative breast cancer ...

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...